Zenocutuzumab Shows Efficacy in Patients with Advanced NRG1 Fusion-positive Cancers By Ogkologos - February 19, 2025 852 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the eNRGy study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary Angiography is Safe in Patients with Cancer and Suspected Pulmonary Embolism MOST POPULAR Weak Immunogenicity in Patients with Cancer After First Dose of mRNA-based... May 18, 2021 How TRACERx is helping us predict lung cancer’s next move April 12, 2023 Assisted Reproduction Treatments are Safe in Young Breast Cancer Survivors with... May 15, 2024 Bariatric Surgery May Reduce the Risk of Some Common Cancers December 2, 2022 Load more HOT NEWS Addressing Cancer Disparities and New Research in Treating HPV-Positive Head and... The path to least resistance: How our researchers are outsmarting cancer’s... Longtime NPR Reporter Shares Diagnosis to Bring More Awareness to Metastatic... How Fatty Liver Disease Helps Cancer Thrive in the Liver
